/
SNWV
$9.85+$1.24 (+14.40%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$74.0M
9M shares
52-week range
$7.53 – $46.59
6% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
1.36%
Moderate
Price (6 mo)
Loading chart…
Change$-53.90
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9M | $1.0M | $4.1M | $13.0M | $16.7M | $20.4M | $32.6M | $44.1M |
| Cost of revenue | $693.7K | $538.9K | $1.2M | $5.0M | $4.3M | $6.0M | $8.1M | $10.1M |
| Gross profit | $1.2M | $489.8K | $2.9M | $8.0M | $12.4M | $14.4M | $24.6M | $34.0M |
| Gross margin | 62.5% | 47.6% | 71.4% | 61.7% | 74.1% | 70.4% | 75.2% | 77.1% |
| R&D | $1.7M | $1.2M | $1.2M | $1.1M | $567.0K | $579.0K | $673.0K | $1.4M |
| Operating income | −$7.2M | −$8.8M | −$25.2M | −$14.1M | −$9.0M | −$540.0K | $5.4M | $4.9M |
| EBITDA | −$7.1M | −$8.5M | −$27.4M | −$18.9M | $4.8M | −$9.2M | −$16.6M | $19.4M |
| Net income | −$11.6M | −$10.4M | −$30.9M | −$27.3M | −$10.3M | −$25.8M | −$31.4M | $11.8M |
| Net margin | -628.7% | -1013.9% | -762.6% | -209.5% | -61.5% | -126.5% | -96.1% | 26.8% |
| EPS (diluted) | -29.17 | -19.26 | -30.68 | -19.72 | -7.02 | -12.19 | -7.03 | 0.41 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $51M | $-0.08 | $-0.08–$-0.08 | 1 |
| 2027 | $65M | $0.37 | $0.37–$0.37 | 1 |
| 2028 | $2M | $-18.75 | $-18.75–$-18.75 | 1 |
| 2029 | $5M | $-18.75 | $-18.75–$-18.75 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
SANUWAVE Health, Inc. Common Stock
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
www.sanuwave.com- Employees
- 55
- IPO / List date
- Oct 8, 2008
- HQ
- EDEN PRAIRIE, MN
Held by traders on TradeandTell
No one on the platform currently holds SNWV.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in SNWV as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-10-18 | 1-for-375reverse |
Recent trades on TradeandTell
No one on the platform has traded SNWV yet.
